A Systematic Examination of Burden of Childhood Cancers in 183 Countries: Estimates from GLOBOCAN 2018
- PMID: 33723880
- DOI: 10.1111/ecc.13438
A Systematic Examination of Burden of Childhood Cancers in 183 Countries: Estimates from GLOBOCAN 2018
Abstract
Objective: Childhood cancers are a significant cause of child deaths worldwide. This study examines the burden of 33 childhood cancers in 183 countries.
Methods: The estimates of age-, sex- and country-wise incidence and deaths due to 33 childhood cancers (below the age 15) for 183 countries were retrieved from GLOBOCAN 2018. The socioeconomic status of a country was measured by human development index (HDI).
Results: Globally, an estimated 200 166 cases and 74 956 deaths were attributed to childhood cancers in 2018. The age-standardised incidence rate (ASIR) was 103 per million, whereas the age-standardised mortality rate (ASMR) stood at 38 per million. ASIR was highest in high-income regions (e.g. North America: 182 per million); ASMR, however, was elevated in low- and medium-income countries (e.g. south-east Asia: 62 per million; North Africa: 51 per million). Leukaemia and brain cancers were dominant cancer groups accounting for 45% of cases and 57% of deaths. The ASIRs exhibited a positive gradient with HDI ( .
Conclusion: The high burden of childhood cancers (>80% of total incidence) in low- and middle-income countries (LMICs) calls for increased cancer awareness, improvement in oncologic infrastructure, international collaborations and twinning programmes, equitable access to multi-modal treatment and financial coverage of treatment expenses.
Keywords: GLOBOCAN; Incidence; Mortality; Paediatric Cancer.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018.Breast Cancer Res Treat. 2021 Jun;187(2):557-567. doi: 10.1007/s10549-020-06083-6. Epub 2021 Jan 30. Breast Cancer Res Treat. 2021. PMID: 33515396
-
Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data.Chin Med J (Engl). 2024 Dec 20;137(24):3108-3116. doi: 10.1097/CM9.0000000000003420. Epub 2024 Dec 13. Chin Med J (Engl). 2024. PMID: 39668405 Free PMC article.
-
An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018.EPMA J. 2019 Sep 11;11(1):95-117. doi: 10.1007/s13167-019-00185-y. eCollection 2020 Mar. EPMA J. 2019. PMID: 32140188 Free PMC article.
-
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16. Lancet Respir Med. 2021. PMID: 34411511 Free PMC article.
-
The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.Glob Heart. 2014 Mar;9(1):101-6. doi: 10.1016/j.gheart.2014.01.003. Glob Heart. 2014. PMID: 25432119 Review.
Cited by
-
Development and user evaluation of an online caregiver education resource for Malaysian parents of children with leukemia or lymphoma.Asia Pac J Oncol Nurs. 2023 Dec 20;11(2):100363. doi: 10.1016/j.apjon.2023.100363. eCollection 2024 Feb. Asia Pac J Oncol Nurs. 2023. PMID: 38304227 Free PMC article.
-
Relative risk of childhood and adolescence cancer in Iran: spatiotemporal analysis from 1999 to 2016.BMC Res Notes. 2024 Jan 18;17(1):29. doi: 10.1186/s13104-023-06629-z. BMC Res Notes. 2024. PMID: 38238811 Free PMC article.
-
Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study.Lancet Reg Health Southeast Asia. 2024 Jan 2;21:100333. doi: 10.1016/j.lansea.2023.100333. eCollection 2024 Feb. Lancet Reg Health Southeast Asia. 2024. PMID: 38361599 Free PMC article.
-
Increasing pediatric radiation oncology capacity in sub-saharan Africa using technology: a pilot of a pediatric radiation oncology virtual training course.BMC Med Educ. 2024 Mar 20;24(1):317. doi: 10.1186/s12909-024-05313-5. BMC Med Educ. 2024. PMID: 38509515 Free PMC article.
-
Determining the cost and cost-effectiveness of childhood cancer treatment in Haiti.Ecancermedicalscience. 2024 Feb 28;18:1675. doi: 10.3332/ecancer.2024.1675. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38439808 Free PMC article.
References
REFERENCES
-
- Afungchwi, G. M., Hesseling, P. B., & Ladas, E. J. (2017). The role of traditional healers in the diagnosis and management of Burkitt lymphoma in Cameroon: understanding the challenges and moving forward. BMC Complementary and Alternative Medicine, 17(1), 209. https://doi.org/10.1186/s12906-017-1719-y
-
- Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., … Ogunbiyi, O. J. (2018). Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet, 391(10125), 1023-1075. https://doi.org/10.1016/S0140-6736(17)33326-3
-
- Amitay, E. L. & Keinan-Boker, L. (2015). Breastfeeding and childhood leukemia incidence: A meta-analysis and systematic review. JAMA Pediatrics, 169(6), e151025. https://doi.org/10.1001/jamapediatrics.2015.1025
-
- Arora, R. S., Eden, T. O. B., & Kapoor, G. (2009). Epidemiology of childhood cancer in India. Indian Journal of Cancer, 46(4), 264-273. https://doi.org/10.4103/0019-509X.55546
-
- Asadzadeh Vostakolaei, F., Karim-Kos, H. E., Janssen-Heijnen, M. L., Visser, O., Verbeek, A. L., & Kiemeney, L. A. (2011). The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health, 21(5), 573-577. https://doi.org/10.1093/eurpub/ckq120
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical